Sichuan Kelun Medicine & Trade Co., Ltd. Sustainability Profile
Sichuan Kelun Medicine & Trade Co., Ltd., commonly referred to as Kelun, is a prominent player in the pharmaceutical industry, headquartered in Chengdu, Sichuan, China. Established in 1997, the company has made significant strides in the development and distribution of high-quality pharmaceutical products, particularly in the fields of oncology and anaesthesia. Kelun's core offerings include a diverse range of injectable drugs and active pharmaceutical ingredients (APIs), distinguished by their rigorous quality standards and innovative formulations. With a strong presence in both domestic and international markets, Kelun has earned recognition for its commitment to research and development, positioning itself as a leader in the pharmaceutical sector. Notable achievements include multiple certifications from global regulatory bodies, underscoring Kelun's dedication to excellence and safety in healthcare. As a result, the company continues to expand its influence, contributing to advancements in medical treatments worldwide.
DitchCarbon Score
How does Sichuan Kelun Medicine & Trade Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sichuan Kelun Medicine & Trade Co., Ltd.'s score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sichuan Kelun Medicine & Trade Co., Ltd., headquartered in China (CN), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd., which may influence its climate-related initiatives and commitments. As of now, there are no documented reduction targets or climate pledges from Sichuan Kelun Medicine & Trade Co., Ltd. This lack of specific commitments may reflect a broader industry context where many pharmaceutical companies are increasingly focusing on sustainability and carbon reduction strategies. Given the absence of direct emissions data and reduction initiatives, it is essential for Sichuan Kelun Medicine & Trade Co., Ltd. to consider establishing measurable climate commitments and targets to align with global sustainability trends and expectations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 2,190,590,170 | 0,000,000,000 |
| Scope 2 | 468,869,750 | 000,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Sichuan Kelun Medicine & Trade Co., Ltd.'s Industry?
How Carbon Intensive is Sichuan Kelun Medicine & Trade Co., Ltd.'s Location?
Sichuan Kelun Medicine & Trade Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sichuan Kelun Medicine & Trade Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
